Atlas Trials

Neurofibromatosis Type 2

19 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Neurofibromatosis Type 2

RecordFirmDate
Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas (NCT05130866)Recursion Pharmaceuticals Inc.2022-06-20
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2) (NCT04374305)Scott R. Plotkin, MD, PhD2020-06-20
WES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data (NCT03210285)University Hospital Tuebingen2017-07-31
Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors (NCT02934256)Li Peng2016-07-01
Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma (NCT02282917)Massachusetts Eye and Ear Infirmary2015-12-01
Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma (NCT01345136)Jonsson Comprehensive Cancer Center2015-07-01
Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas (NCT02129647)NYU Langone Health2014-04-01
Effect of Implant Position on Magnetic Resonance Image Distortion (NCT02246231)Manchester University NHS Foundation Trust2014-02-03
Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas (NCT01880749)NYU Langone Health2013-06-01
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas (NCT01767792)University of Alabama at Birmingham2013-05-15
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease (NCT01552434)M.D. Anderson Cancer Center2012-10-16
Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2) (NCT01207687)National Cancer Institute (NCI)2010-10-01
Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas (NCT01125046)Northwestern University2010-06-17
Compassionate Use Arm - ABI541 ABI for 10 NF2 Patients (NCT02589912)Massachusetts Eye and Ear Infirmary

Track Neurofibromatosis Type 2 automatically

Every clearance here is in the API, with alerts when new ones post.